Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Nuclear Medicine

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 54 articles:
HTML format
Text format



Single Articles


    November 2018
  1. MAHLER C, Unterrainer M, Muth C, Egensperger R, et al
    Imaging microglial activation in tacrolimus-associated CNS vasculitis with translocator protein PET.
    Neurology. 2018;91:936-937.
    PubMed     Text format    


    September 2018
  2. HAMMOUD DA, Sinharay S, Steinbach S, Wakim PG, et al
    Global and regional brain hypometabolism on FDG-PET in treated HIV-infected individuals.
    Neurology. 2018 Sep 26. pii: WNL.0000000000006398.
    PubMed     Text format     Abstract available


  3. BAHEERATHAN A, McNamara C, Kalam S, Rane N, et al
    The utility of FDG-PET imaging in distinguishing PML-IRIS from PML in a patient treated with natalizumab.
    Neurology. 2018;91:572-573.
    PubMed     Text format    


    August 2018
  4. CRISWELL SR, Warden MN, Searles Nielsen S, Perlmutter JS, et al
    Selective D2 receptor PET in manganese-exposed workers.
    Neurology. 2018 Aug 10. pii: WNL.0000000000006163.
    PubMed     Text format     Abstract available


  5. ASCHENBRENNER AJ, Gordon BA, Benzinger TLS, Morris JC, et al
    Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease.
    Neurology. 2018 Aug 1. pii: WNL.0000000000006075.
    PubMed     Text format     Abstract available


    July 2018
  6. MARANGI A, Tagliapietra M, Vicenzi V, Pasquin I, et al
    Teaching NeuroImages: Brain MRI and DaT-SPECT imaging in adult GM1 gangliosidosis.
    Neurology. 2018;91:e187-e188.
    PubMed     Text format    


    March 2018
  7. HUANG YS, Hsiao IT, Liu FY, Hwang FM, et al
    Neurocognition, sleep, and PET findings in type 2 vs type 1 narcolepsy.
    Neurology. 2018 Mar 30. pii: WNL.0000000000005346.
    PubMed     Text format     Abstract available


  8. HUGHES TM, Wagenknecht LE, Craft S, Mintz A, et al
    Arterial stiffness and dementia pathology: Atherosclerosis Risk in Communities (ARIC)-PET Study.
    Neurology. 2018 Mar 16. pii: WNL.0000000000005259.
    PubMed     Text format     Abstract available


    February 2018
  9. PILOTTO A, Premi E, Paola Caminiti S, Presotto L, et al
    Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease.
    Neurology. 2018 Feb 16. pii: WNL.0000000000005161.
    PubMed     Text format     Abstract available


  10. JONES DT, Knopman DS, Graff-Radford J, Syrjanen JA, et al
    In vivo (18)F-AV-1451 tau-PET signal in MAPT mutation carriers varies by expected tau isoforms.
    Neurology. 2018 Feb 9. pii: WNL.0000000000005117.
    PubMed     Text format     Abstract available


  11. DAY GS, Gordon BA, Perrin RJ, Cairns NJ, et al
    In vivo [(18)F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob disease.
    Neurology. 2018 Feb 7. pii: WNL.0000000000005064.
    PubMed     Text format     Abstract available


    January 2018
  12. OTTO M
    Tau CSF proteins for diagnosis but tau PET imaging for AD diagnosis and staging.
    Neurology. 2018 Jan 10. pii: WNL.0000000000004902.
    PubMed     Text format    


    December 2017
  13. LA JOIE R, Bejanin A, Fagan AM, Ayakta N, et al
    Associations between [(18)F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample.
    Neurology. 2017 Dec 27. pii: WNL.0000000000004860.
    PubMed     Text format     Abstract available


  14. GONNEAUD J, Arenaza-Urquijo EM, Mezenge F, Landeau B, et al
    Increased florbetapir binding in the temporal neocortex from age 20 to 60 years.
    Neurology. 2017;89:2438-2446.
    PubMed     Text format     Abstract available


    November 2017
  15. GROTHE MJ, Barthel H, Sepulcre J, Dyrba M, et al
    In vivo staging of regional amyloid deposition.
    Neurology. 2017;89:2031-2038.
    PubMed     Text format     Abstract available


  16. VOGEL JW, Varga Dolezalova M, La Joie R, Marks SM, et al
    Subjective cognitive decline and beta-amyloid burden predict cognitive change in healthy elderly.
    Neurology. 2017;89:2002-2009.
    PubMed     Text format     Abstract available


    October 2017
  17. CHETELAT G, Murray ME
    Amyloid PET scan: Staging beyond reading?
    Neurology. 2017 Oct 18. pii: 10.1212/WNL.0000000000004678.
    PubMed     Text format    


  18. MOLLENHAUER B, Caspell-Garcia CJ, Coffey CS, Taylor P, et al
    Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls.
    Neurology. 2017 Oct 13. pii: 10.1212/WNL.0000000000004609.
    PubMed     Text format     Abstract available


  19. ROBERTS RO, Knopman DS, Syrjanen JA, Aakre JA, et al
    Weighting and standardization of frequencies to determine prevalence of AD imaging biomarkers.
    Neurology. 2017 Oct 13. pii: 10.1212/WNL.0000000000004652.
    PubMed     Text format     Abstract available


    September 2017
  20. CHO H, Baek MS, Choi JY, Lee SH, et al
    18F-AV-1451 binds to motor-related subcortical gray and white matter in corticobasal syndrome.
    Neurology. 2017;89:1170-1178.
    PubMed     Text format     Abstract available


  21. LIM YY, Mormino EC
    APOE genotype and early beta-amyloid accumulation in older adults without dementia.
    Neurology. 2017;89:1028-1034.
    PubMed     Text format     Abstract available


    August 2017
  22. CHARIDIMOU A, Farid K, Baron JC
    Amyloid-PET in sporadic cerebral amyloid angiopathy: A diagnostic accuracy meta-analysis.
    Neurology. 2017 Aug 30. pii: 10.1212/WNL.0000000000004539.
    PubMed     Text format     Abstract available


  23. RAPOSO N, Sonnen JA
    Amyloid-PET in cerebral amyloid angiopathy: Detecting vascular amyloid deposits, not just blood.
    Neurology. 2017 Aug 30. pii: 10.1212/WNL.0000000000004548.
    PubMed     Text format    


  24. MOSCONI L, Berti V, Quinn C, McHugh P, et al
    Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging.
    Neurology. 2017 Aug 30. pii: 10.1212/WNL.0000000000004425.
    PubMed     Text format     Abstract available


  25. NEDELSKA Z, Przybelski SA, Lesnick TG, Schwarz CG, et al
    1H-MRS metabolites and rate of beta-amyloid accumulation on serial PET in clinically normal adults.
    Neurology. 2017 Aug 25. pii: 10.1212/WNL.0000000000004421.
    PubMed     Text format     Abstract available


  26. SMITH R, Scholl M, Widner H, van Westen D, et al
    In vivo retention of 18F-AV-1451 in corticobasal syndrome.
    Neurology. 2017;89:845-853.
    PubMed     Text format     Abstract available


    July 2017
  27. RAPOSO N, Planton M, Peran P, Payoux P, et al
    Florbetapir imaging in cerebral amyloid angiopathy-related hemorrhages.
    Neurology. 2017 Jul 19. pii: 10.1212/WNL.0000000000004228.
    PubMed     Text format     Abstract available


  28. NICCOLINI F, Wilson H, Pagano G, Coello C, et al
    Loss of phosphodiesterase 4 in Parkinson disease: Relevance to cognitive deficits.
    Neurology. 2017 Jul 12. pii: 10.1212/WNL.0000000000004201.
    PubMed     Text format     Abstract available


  29. SIERRA M, Martinez-Rodriguez I, Sanchez-Juan P, Gonzalez-Aramburu I, et al
    Prospective clinical and DaT-SPECT imaging in premotor LRRK2 G2019S-associated Parkinson disease.
    Neurology. 2017 Jul 5. pii: 10.1212/WNL.0000000000004185.
    PubMed     Text format     Abstract available


    June 2017
  30. BUCKLEY RF, Schultz AP, Hedden T, Papp KV, et al
    Functional network integrity presages cognitive decline in preclinical Alzheimer disease.
    Neurology. 2017 Jun 7. pii: 10.1212/WNL.0000000000004059.
    PubMed     Text format     Abstract available


    May 2017
  31. CARRERA E, Wintermark M
    Imaging-based selection of patients for acute stroke treatment: Is it ready for prime time?
    Neurology. 2017 May 17. pii: 10.1212/WNL.0000000000004051.
    PubMed     Text format    


  32. HOSSACK M, McClean J
    Pure sensory ganglionopathy as the first sign of relapse in non-Hodgkin lymphoma.
    Neurology. 2017;88:1976-1977.
    PubMed     Text format    


  33. VANNINI P, Hanseeuw B, Munro CE, Amariglio RE, et al
    Hippocampal hypometabolism in older adults with memory complaints and increased amyloid burden.
    Neurology. 2017;88:1759-1767.
    PubMed     Text format     Abstract available


    April 2017
  34. LI Y, Kang W, Yang Q, Zhang L, et al
    Predictive markers for early conversion of iRBD to neurodegenerative synucleinopathy diseases.
    Neurology. 2017;88:1493-1500.
    PubMed     Text format     Abstract available


  35. NG KP, Pascoal TA, Mathotaarachchi S, Chung CO, et al
    Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease.
    Neurology. 2017 Apr 12. pii: 10.1212/WNL.0000000000003916.
    PubMed     Text format     Abstract available


    March 2017
  36. DASILVA AF, Nascimento TD, Jassar H, Heffernan J, et al
    Dopamine D2/D3 imbalance during migraine attack and allodynia in vivo.
    Neurology. 2017 Mar 29. pii: 10.1212/WNL.0000000000003861.
    PubMed     Text format     Abstract available


  37. SAARI L, Kivinen K, Gardberg M, Joutsa J, et al
    Dopamine transporter imaging does not predict the number of nigral neurons in Parkinson disease.
    Neurology. 2017 Mar 10. pii: 10.1212/WNL.0000000000003810.
    PubMed     Text format     Abstract available


  38. PAPP KV, Rentz DM, Mormino EC, Schultz AP, et al
    Cued memory decline in biomarker-defined preclinical Alzheimer disease.
    Neurology. 2017 Mar 10. pii: 10.1212/WNL.0000000000003812.
    PubMed     Text format     Abstract available


    February 2017
  39. FRANZMEIER N, Duering M, Weiner M, Dichgans M, et al
    Left frontal cortex connectivity underlies cognitive reserve in prodromal Alzheimer disease.
    Neurology. 2017 Feb 10. pii: 10.1212/WNL.0000000000003711.
    PubMed     Text format     Abstract available


  40. GROTHE MJ, Villeneuve S, Dyrba M, Bartres-Faz D, et al
    Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load.
    Neurology. 2017;88:569-576.
    PubMed     Text format     Abstract available


    January 2017
  41. THOMAS AJ, Attems J, Colloby SJ, O'Brien JT, et al
    Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB.
    Neurology. 2017;88:276-283.
    PubMed     Text format     Abstract available


    November 2016
  42. SETHI M, Kowalczyk MA, Dalic LJ, Archer JS, et al
    Abnormal neurovascular coupling during status epilepticus migrainosus in Sturge-Weber syndrome.
    Neurology. 2016 Nov 30. pii: 10.1212/WNL.0000000000003492.
    PubMed     Text format    


  43. PAGANO G, Molloy S, Bain PG, Rabiner EA, et al
    Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson disease.
    Neurology. 2016 Nov 2. pii: 10.1212/WNL.0000000000003396.
    PubMed     Text format     Abstract available


    October 2016
  44. MATTIS PJ, Niethammer M, Sako W, Tang CC, et al
    Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases.
    Neurology. 2016 Oct 5. pii: 10.1212/WNL.0000000000003285.
    PubMed     Text format     Abstract available


    September 2016
  45. MATTSSON N, Zetterberg H, Janelidze S, Insel PS, et al
    Plasma tau in Alzheimer disease.
    Neurology. 2016 Sep 30. pii: 10.1212/WNL.0000000000003246.
    PubMed     Text format     Abstract available


  46. VAUGHAN DN, Rayner G, Tailby C, Jackson GD, et al
    MRI-negative temporal lobe epilepsy: A network disorder of neocortical connectivity.
    Neurology. 2016 Sep 30. pii: 10.1212/WNL.0000000000003289.
    PubMed     Text format     Abstract available


    August 2016
  47. BURNHAM SC, Rowe CC, Baker D, Bush AI, et al
    Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-up.
    Neurology. 2016 Aug 17. pii: 10.1212/WNL.0000000000003094.
    PubMed     Text format     Abstract available


    July 2016
  48. KNOPMAN DS, Jack CR Jr, Wiste HJ, Weigand SD, et al
    Age and neurodegeneration imaging biomarkers in persons with Alzheimer disease dementia.
    Neurology. 2016 Jul 15. pii: 10.1212/WNL.0000000000002979.
    PubMed     Text format     Abstract available


  49. MORMINO EC, Sperling RA, Holmes AJ, Buckner RL, et al
    Polygenic risk of Alzheimer disease is associated with early- and late-life processes.
    Neurology. 2016 Jul 6. pii: 10.1212/WNL.0000000000002922.
    PubMed     Text format     Abstract available


    May 2016
  50. VASSILAKI M, Aakre JA, Mielke MM, Geda YE, et al
    Multimorbidity and neuroimaging biomarkers among cognitively normal persons.
    Neurology. 2016;86:2077-84.
    PubMed     Text format     Abstract available


  51. VOEVODSKAYA O, Sundgren PC, Strandberg O, Zetterberg H, et al
    Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease.
    Neurology. 2016;86:1754-61.
    PubMed     Text format     Abstract available


    April 2016
  52. INSEL PS, Mattsson N, Mackin RS, Scholl M, et al
    Accelerating rates of cognitive decline and imaging markers associated with beta-amyloid pathology.
    Neurology. 2016 Apr 15. pii: 10.1212/WNL.0000000000002683.
    PubMed     Text format     Abstract available


    March 2016
  53. LIM YY, Laws SM, Villemagne VL, Pietrzak RH, et al
    Abeta-related memory decline in APOE epsilon4 noncarriers: Implications for Alzheimer disease.
    Neurology. 2016 Mar 30. pii: 10.1212/WNL.0000000000002604.
    PubMed     Text format     Abstract available


  54. LANDAU SM, Horng A, Fero A, Jagust WJ, et al
    Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI.
    Neurology. 2016 Mar 11. pii: 10.1212/WNL.0000000000002576.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: